Neurocrine Biosciences, Inc. (NBIX)

NASDAQ: NBIX · Real-Time Price · USD

146.23

-5.60 (-3.69%)

At close: Sep 18, 2026, 4:00 PM EDT

146.63

+0.40 (0.27%)

After-hours: Sep 18, 2026, 7:55 PM EDT

Neurocrine Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,374	2,861	2,355	1,887	1,489	1,134
Revenue Growth	34.42%	21.45%	24.81%	26.76%	31.34%	8.38%
Cost of Revenue	1,198	1,068	765.1	604.7	487	342.4
Gross Profit	2,176	1,793	1,590	1,282	1,002	791.1
Selling, General & Admin	1,295	1,156	993.2	887.6	752.7	583.3
Operating Expenses	1,310	1,156	993.2	887.6	752.7	583.3
Operating Income	866	636.5	597	394.8	249	207.8
Interest Expense	-2.9	-	-	-	-	-25.8
Interest & Investment Income	88.5	90.3	91	52.8	4.1	3.8
EBT Excluding Unusual Items	951.6	726.8	688	447.6	253.1	185.8
Gain (Loss) on Sale of Investments	59.8	-4	-37.1	28.4	30.8	20.9
Gain (Loss) on Sale of Assets	28.6	-	-	-	-	-
Asset Writedown	-	-	-14	-	-	-
Other Unusual Items	-	-	-138.4	-	-70	-
Pretax Income	940.2	705.4	486	332.1	213.9	101.4
Income Tax Expense	234.7	226.8	144.7	82.4	59.4	11.8
Net Income	705.5	478.6	341.3	249.7	154.5	89.6
Net Income to Common	705.5	478.6	341.3	249.7	154.5	89.6
Net Income Growth	102.55%	40.23%	36.68%	61.62%	72.43%	-78.00%
Shares Outstanding (Basic)	100	100	100	98	96	95
Shares Outstanding (Diluted)	104	103	104	101	99	98
Shares Change	0.78%	-1.16%	2.67%	2.12%	1.02%	0.10%
EPS (Basic)	7.04	4.81	3.40	2.56	1.61	0.95
EPS (Diluted)	6.82	4.67	3.29	2.47	1.56	0.92
EPS Growth	101.21%	41.95%	33.20%	58.33%	69.56%	-77.89%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	870.4	748.7	557.2	361.6	322.9	233.1
Free Cash Flow Per Share	8.41	7.30	5.37	3.58	3.27	2.38
Gross Margin	64.48%	62.67%	67.52%	67.96%	67.29%	69.79%
Operating Margin	25.67%	22.25%	25.35%	20.92%	16.73%	18.33%
Profit Margin	20.91%	16.73%	14.49%	13.23%	10.38%	7.90%
Free Cash Flow Margin	25.80%	26.17%	23.66%	19.16%	21.69%	20.57%
EBITDA	913.3	666.6	624.1	416.1	264.6	218.7
EBITDA Margin	27.07%	23.30%	26.50%	22.05%	17.77%	19.29%
D&A For EBITDA	47.3	30.1	27.1	21.3	15.6	10.9
EBIT	866	636.5	597	394.8	249	207.8
EBIT Margin	25.67%	22.25%	25.35%	20.92%	16.73%	18.33%
Effective Tax Rate	24.96%	32.15%	29.77%	24.81%	27.77%	11.64%
Revenue as Reported	3,374	2,861	2,355	1,887	1,489	1,134
Advertising Expenses	-	226.8	191	159.9	149.7	139.8

SEC Filings: 10-K · 10-Q